CRIS · Curis Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 0.71 USD |
|---|---|
| 1-day change | +8.2% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 36 / 2 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 38 / 10 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +351.0% |
| Sales growth Q/Q | -64.2% |
| Distance from 52-week high | +97.6% |
| Market cap (USD) | $24.3M |